EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma

Ryu Matsumoto iD, Kiyonori Tanoue iD, Chieri Nakayama, Masashi Okawa, Yuto Hozaka iD, Tetsuya Idichi, Yuko Mataki iD, Takao Ohtsuka

Cancers · 22.09.2025 · 17 (18) · 3090

DOI: 10.3390/cancers17183090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.09.2025. Verfasst von Ryu Matsumoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, JSPS KAKENHI Grants-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a critical disease requiring the development of novel effective therapeutic approaches due to its increasing global incidence and associated low survival rates. While immunotherapy, including immune checkpoint inhibitors, has shown efficacy against various tumors, developing an effective treatment approach for PDAC poses a challenge. This is primarily attributed to the complex and distinctive immune evasion mechanisms of PDAC. Recent studies have revealed that tumor-associated macrophages (TAMs) play a crucial role in enhancing immune evasion in PDAC. This role is mediated through multiple pathways, including cytokine secretion and the activation or suppression of diverse immune cells. A clear understanding of how macrophages contribute to PDAC proliferation could lead to the development of novel immune therapy approaches targeting TAMs. In this review, we summarized the multifaceted activities and roles of TAMs in PDAC and explored the potential effect of immunotherapeutic approaches on PDAC, with a particular focus on chimeric antigen receptor (CAR) macrophages. This review was based on promising findings from recent studies on CAR macrophage-based immunotherapy for solid tumors.

Schlagwörter

Stichwörter der Autor:innen

immunotherapypancreatic ductal adenocarcinomatumor-associated macrophages

Autor:innen und Institutionen

  • Department of Digestive Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
  • Shin Nippon Biomedical Laboratories, Miyanoura-cho, Kagoshima 891-1305, Japan.

ORCID-Profile: Ryu Matsumoto, Kiyonori Tanoue, Yuto Hozaka, Yuko Mataki

Förderung

  • JSPS KAKENHI
  • JSPS KAKENHI Grants-in-Aid for Scientific Research

Zitieren

APA

Matsumoto, R., Tanoue, K., Nakayama, C., Okawa, M., Hozaka, Y., Idichi, T., Mataki, Y., & Ohtsuka, T. (2025). Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma. Cancers, 17(18), 3090. https://doi.org/10.3390/cancers17183090

Vancouver

Matsumoto R, Tanoue K, Nakayama C, Okawa M, Hozaka Y, Idichi T, et al. Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma. Cancers. 2025;17(18):3090. doi:10.3390/cancers17183090

BibTeX
@article{Matsumoto2025,
  author = {Matsumoto, Ryu and Tanoue, Kiyonori and Nakayama, Chieri and Okawa, Masashi and Hozaka, Yuto and Idichi, Tetsuya and Mataki, Yuko and Ohtsuka, Takao},
  title = {Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {18},
  pages = {3090},
  doi = {10.3390/cancers17183090}
}
Kostenlos starten →